zm 241385 has been researched along with Hypertension in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borea, PA; Cattabriga, E; Iannotta, V; Manfredini, R; Pancaldi, C; Portaluppi, F; Uluoglu, C; Varani, K | 1 |
Brooks, R; Keddie, JR; McKillop, D; Poucher, SM; Shaw, GR | 1 |
1 trial(s) available for zm 241385 and Hypertension
Article | Year |
---|---|
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension.
Topics: Adenosine-5'-(N-ethylcarboxamide); Adult; Antihypertensive Agents; Binding, Competitive; Blood Pressure; Body Mass Index; Cyclic AMP; Diastole; Doxazosin; Female; Humans; Hypertension; Lymphocytes; Male; Middle Aged; Neutrophils; Propranolol; Radioligand Assay; Receptor, Adenosine A2A; Receptors, Purinergic P1; Reference Values; Systole; Treatment Outcome; Triazines; Triazoles | 2002 |
1 other study(ies) available for zm 241385 and Hypertension
Article | Year |
---|---|
Pharmacodynamics of ZM 241385, a potent A2a adenosine receptor antagonist, after enteric administration in rat, cat and dog.
Topics: Administration, Oral; Animals; Cats; Dogs; Drug Interactions; Female; Hemodynamics; Hypertension; Injections, Intravenous; Intubation, Gastrointestinal; Male; Purinergic P1 Receptor Antagonists; Rats; Species Specificity; Theophylline; Triazines; Triazoles; Vasodilation; Vasodilator Agents | 1996 |